Technical Analyst, Deepak Mohoni is of the view that Dr. Reddy has been on a fairly steady uptrend since February but if the investors wants some different pharma pick may be Divis Laboratories would be the best.

Mohoni told CNBC-TV18, "I think Dr. Reddy has been on a fairly steady uptrend since February. As the sporadic moves like yesterday’s and some reactions after that but the trend is up and pharma is not an underperformer for the last 2-3 months at least going with the markets it is not a bit stronger. If the investors wants some different pharma pick may be Divis Labs would be the best."